DCK and acute lymphoblastic leukemia: Simultaneous targeting of dCK with the small molecule inhibitor DI-39 and RNR with dT in acute lymphoblastic leukemia (ALL) cancer cells induced replication stress and apoptosis confirming synergy between de novo dCTP inhibition and pyrimidine salvage inhibition (Figure 2B).